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Abstract 
The present study aimed to determine the role of IL12
-1188 genetic polymorphism in susceptibility or resistant to 
visceral Leishmaniasis (VL) by studying single nucleotide polymorphism (SNP) in the gene of IL12B at position 
-1188 in 44 Iraqi VL patients and 40 healthy controls. IL-12 serum level showed no significant difference 
between patients and controls (5.33 ± 3.26 vs.2.17 ± 0.36 pg/ml). In addition, SNP analysis revealed that neither 
genotypes nor alleles of IL12B
-1188 revealed a significant variation between VL patients and controls. To 
determine the impact of IL12B
-1188 genotypes on IL-12 serum level, VL patients and controls were distributed 
according to their serum level in the three genotypes of this cytokine. It was found that IL12
-1188 CC genotype 
demonstrated a significant increased level of IL-12 (26.16 ±19.76 pg/ml) in patients compared to CA and AA 
genotype (1.35 ± 0.35 pg/ml and 1.48 ± 0.23 pg/ml respectively) of patients. 
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1. Introduction    
Leishmaniasis is one of the vector-borne diseases caused by obligate protozoan parasites of the genus 
Leishmania. They are transmitted by different species of sand flies belong the genus Phlebotomine as 
extracellular flagellated promastigotes that replicate as intracellular parasite (aflagellate amastigotes) in 
mononuclear cells of mammalian hosts (Bates 2007). The disease ranges from asymptomatic self-healing 
infection to localized lesions in the skin, but can also develop into a progressive life-threatening visceral form of 
disease (Griensven & Diro 2012).  It is one of the important parasitic diseases, affecting mainly low social class 
peoples in developing countries, and is more prevalent and endemic in the tropical and subtropical regions of 
Africa, Asia, the Mediterranean, Southern Europe (old world) and South and Central America (new world) 
(Alvar et al. 2012).  
The protective immunity against L. donovani has been suggested to be dependent on IL-12-driven Th1 
response and production of IFN-γ; thus an induction of parasite killing can result by macrophages primarily via 
reactive nitrogen and oxygen intermediates production (Shio et al. 2012). A further effect of IL-12 was 
associated with a decrease of spontaneous or antigen-induced peripheral blood mononuclear cell (PBMC) 
apoptosis in VL patients, and using IL-12 in combination with Leishmania antigens in vitro restored PBMC 
proliferation in VL patients more efficiently than the use of anti-IL-4 or anti-IL-10 monoclonal antibodies (Singh 
et al. 2012).  
A number of studies have investigated the role of genetic polymorphisms at candidate immune response 
genes that are associated with pro- and anti-inflammatory responses (i.e. cytokine genes) in regulating the 
clinical outcome of leishmaniasis in human (Hajilooi et al. 2013).The IL12B
-1188 SNP has been shown to 
influence the production of IL-12 or protein expression, and it has also been associated with diseases that are 
Th1-mediated immune responses (Liu et al. 2012). This polymorphism has not been investigated in VL, while in 
CL, there has been one study that showed no significant variation between the IL12B
-1188 genotypes or alleles in 
Brazilian patients (de Jesus Fernandes Covas et al. 2013). 
 
2. Materials and Methods 
2.1 Subjects   
A total of 84 Iraqi Arab children (age range; 4 months to 12 years) were enrolled in the study. They were 
distributed as 44 visceral leishmaniasis (VL) patients and 40 apparently healthy controls. The patients were 
hospitalized cases and they were admitted to ten hospitals in Baghdad and Wasit during the period March 2013- 
February 2014. After a clinical examination of the patient by the medical staff at the hospitals, the serum was 
first screened for anti-VL antibodies by rapid immune-chromatographic strip test (Kalazar Detect™ Test kit: 
InBios International, USA), and if the test was positive the serum was further tested by indirect fluorescent 
antibody test (IFAT) for VL at the Central Public Health Laboratories. 
 
2.2 Collection of Blood Samples 
From each participating subject (patient and control), about 5 ml of venous blood were collected. The blood was 
distributed into two aliquots; the first was dispensed in a plain tube to collect serum, while the second aliquot 
was drawn in EDTA tube and stored at -20°C until DNA extraction. The serum was used for sero-diagnosis of 
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VL and assessment of IL-12 level, while EDTA blood was used to extract DNA for the determination of IL12B 
gene polymorphism. 
2.3 Serum Level of IL-12  
Serum level of IL-12 was determined by ELISA method using Abcam Cytokine kit (USA), which was designed 
for the quantitative measurement of IL-12 in human sera, and instructions of manufacturer were followed. 
 
2.4 Genomic DNA Extraction 
Genomic DNA was extracted from the peripheral blood leukocytes (frozen EDTA blood samples) by Qiagen 
spin column technology (DNeasy blood kit: Qiagen, USA). The DNA concentration was measured by two 
methods. In the first, Nanodrop UV spectrophotometer was used; by which the optical density of DNA (2 µl) 
was measured at two wavelengths (260 and 280 nm).In most samples, DNA preparation gave A260/A280 ratio 
between 1.6 and 2.0, which was considered to be suitable for a further analysis in determining cytokine gene 
polymorphisms. The Nanodrop was also employed to assess the DNA concentration. After that, gel 
electrophoresis was used to confirm the existence of DNA in the samples (Kaur & Mehra 2012).  
 
2.5 Cytokine Gene Polymorphisms 
The Cytokine CTS-PCR-SSP Tray Kit was used to determine the SNP IL12B
-1188. The PCR primers were 
prepared to identify alleles, genotypes. These primers were designed by the Department of Transplantation 
Immunology, University Clinic Heidelberg (Germany) according to the WHO international nomenclature 
committee of cytokines. The electrophoresis of PCR products was run for 20 minutes at 170 volts, and the 
patterns of observed bands of cytokine (alleles) were revealed according to internal control bands. 
 
2.6 Statistical Analysis 
Serum level of IL-12 was statistically analyzed using the computer programme SPSS (Statistical Package for 
Social Sciences) version 13. Their data were given as mean ± standard error (S.E.), and differences between 
means were assessed by ANOVA (Analysis of Variance), followed by LSD (Least Significant Difference) or 
Duncan test. Allele frequencies of IL2
-1188 SNPs were calculated by direct gene counting method, while 
significant departure from Hardy-Weinberg (H-W) equilibrium was assessed by Pearson’s Chi-square test. 
Alleles and genotypes of the SNP were presented as percentage frequencies, and significant differences between 
their distributions in VL patients and controls were assessed by two-tailed Fisher's exact probability (P). In 
addition, relative risk (RR), etiological fraction (EF) and preventive fraction (PF) were also estimated to define 
the association between the SNP alleles and genotypes with the disease (Ad’hiah 1990). These estimations were 
calculated by using the WINPEPI computer programs for epidemiologists. 
 
3. Results 
3.1 Serum Level of Cytokines 
Serum level of IL-12 was increased in VL patients compared to controls (5.33 ± 3.26 vs. 2.17 ± 0.36 pg/ml), but 
the difference failed to attend a significant level (P > 0.05). 
 
3.2 Interlukin-12B Gene Polymorphisms 
Genetic polymorphism of IL12B gene was investigated at the position -1188 (IL12B
-1188), which was presented 
with three genotypes (CC, CA and AA). A significant difference (P ≤ 0.05) was noticed between the observed 
and expected IL12B
-1188 genotype frequencies (i.e. departure from H-W equilibrium) in VL patients, while no 
such departure was observed in controls. In addition, no significant variation between VL patients and controls 
was observed in these genotype or allele frequencies (Tables 1 and 2). 
 
Table 1. Observed numbers and percentage frequencies and Hardy-Weinberg (H-W) equilibrium of IL12B
-1188 
genotypes and alleles in visceral leishmaniasis patients and controls. 




Observed No. 7 13 24 27 61 
0.05 % 15.9 29.5 54.6 30.7 69.3 
Expected No. 4.2 18.7 21.1 Not Estimated % 9.4 42.5 48.1 
Controls 
(No. = 40) 
Observed No. 3 10 27 16 64 
N.S. % 7.5 25.0 67.5 20 80 
Expected No. 1.6 12.8 25.6 Not Estimated % 4.0 32.0 64.0 
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Table 2. Statistical evaluations of associations between IL12B
-1188 genotypes or alleles and visceral leishmaniasis. 
IL12B









CC 2.33 0.09 Not significant 0.57- 9.56 
CA 1.26 0.06 Not significant 0.48- 3.26 
AA 0.58 0.29 Not significant 0.24- 1.39 
C 1.77 0.13 Not significant 0.87- 3.59 
A 0.56 0.34 Not significant 0.28- 1.14 
 
3.3 Impact IL12B
-1188 SNP on serum level of IL-12  
The IL-12
-1188CC genotype in VL patients recorded the highest mean of IL-12 (26.16 ± 19.76 pg/ml), and the 
difference was significant compared to all other genotypes in patients or controls (Figure 1). 
 
 
Figure 1. Serum level of IL-12 in visceral leishmaniasis patients and controls distributed by IL12
-1188 genotypes. 
 
4. Discussion  
Immune responses of the Th1 are characterized by IFN-γ and IL-2, which is the signature cytokine of Th1 
immune response that act on macrophages, NK cells and B cells, and such effects are considered critical for 
Leishmania infection control (Bhattacharya & Ali 2013). The resistance in VL involves CD4+ and CD8+ T cells 
when Th1 responses exert their protective effects through synthesizing IL-2, IFN-γ and IL-12. In contrast, Th2 
responses and through their cytokines (IL-4 and IL-13) are associated with susceptibility or persistence of 
infection, in addition to the role of IL-10, which is linked to Treg cell activation. Therefore, the cellular immune 
response in VL patient has Th1 responses that tend to limit the disease, while Th2 and Treg response are 
associated with disease progression (Kurkjian et al. 2006; Costa et al. 2012; Kamil et al. 2013). Caldas et al. 
(2005) confirmed further that the circulating levels of IL-12 and IFN-γ were elevated in VL patients, and such 
elevation was correlated with the active stage of disease. 
Single nucleotide polymorphisms have been reported to control cytokine gene expression, and 
exacerbated cytokine response in some individuals might be genetically controlled (Medina et al. 2011). Further 
data suggested that cytokine SNPs can be considered as candidate markers of susceptibility and severity of VL, 
and can also influence disease resistance (Stanley & Engwerda 2007; de Jesus Fernandes Covas et al. 2013). 
Interleukin-12 is a heterodimeric cytokine with a molecular weight of 70 kDa that is composed of two 
disulfide linked polypeptide chains: IL-12p35 (35 kDa) and IL-12p40 (40 kDa), which are encoded by IL12A 
and IL12B genes, respectively, but many studies have focused mainly on 3’UTR, at position -1188 A/C (IL12B
-
1188) of IL12B gene, which is located on chromosome 5 at position 5p31-33.2 (Liu et al. 2012). IL-12 functions 
as the main physiological inducer of IFN-γ by activating T cells and promoting Th1-type CD4+ T cell 
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differentiation, and therefore plays an important role in inducing cell-mediated protection in response to 
Leishmania infection (Cummings et al. 2010). In this study, despite of the associated increased risk for VL with 
IL12B
-1188 genotype CC (RR = 2.33) and C allele (RR = 1.77) that may shape a positive association in Iraqi 
patients, the differences failed to attend any significant level. de Jesus Fernandes Covas et al. (2013) also did not 
find a significant association between genotypes and alleles of IL12B
-1188 and Mucocutaneous leishmaniasis 
(MCL) in Brazilian patients. However, the present study pointed out that IL12B
-1188 CC genotype recorded the 
highest level of IL-12 in VL patients; an observation that may highlight the role of such SNP in pathogenesis of 
VL, because the other two genotypes (CA and AA) were observed with very low serum level of IL-12 compared 
to CC genotype, and both genotypes accounted for about 85% of VL cases. Therefore, most VL cases actually 
were presented with low IL-12 level, and this may explain the progression of disease in these cases, because 
immunity against Leishmania has almost been regarded to be dependent on IL-12-driven Th1 response (McCall 
et al. 2013). However, further investigations are certainly required to confirm these findings. 
  
5. Conclusion 
Accordingly, the presented findings promoted to reach the gene polymorphisms of IL12B-1188 might have no 
role in VL susceptibility, or a protection against disease development, but in contrast the IL12-1188 CC SNP 
could be involved in disease pathogenesis through influencing the amount of cytokine released in the patients; 
although it could not prevent the disease development. 
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